Manuel Vega

CEO at AGS Therapeutics

Speaker

Manuel is a biologist and serial entrepreneur with more than 30 years of experience in the biotech sector. Manuel was a postdoc and visiting researcher across leading institutes in Germany, France, and The Netherlands. He was the Founder and CEO of Nautilus Biotech (France and USA), a pioneering biotech company focused on directed evolution of proteins for long-lasting and oral variants (such as long-lasting interferon-alpha and oral human growth hormone). Nautilus Biotech filed INDs with FDA, and secured licensing deals with Aventis Pasteur, Serono, Wyeth Pharma and Hanall Pharmaceuticals. Since 2020, he’s co-founder and CEO of AGS Therapeutics.